LOGIN  |  REGISTER
Amneal Pharmaceuticals
Viking Therapeutics

CVS Health to present at the 2023 Bank of America Securities Health Care Conference and at Bernstein's 39th Annual Strategic Decisions Conference

May 04, 2023 | Last Trade: US$67.49 1.14 1.72

WOONSOCKET, R.I., May 4, 2023 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that Executive Vice President and Chief Financial Officer Shawn Guertin will participate in fireside chats with investors at the 2023 Bank of America Securities Health Care Conference on May 10, 2023, at approximately 8:40 a.m. PT, and at Bernstein's 39th Annual Strategic Decisions Conference on May 31, 2023, at 9 a.m. ET.

An audio webcast of each event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where they will be archived for a period of one year.

About CVS Health 

CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

 

C4 Therapeutics

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page